Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2-Reference-Cited by-同舟云学术

Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2

Published:2014-09-25 Issue:3 Volume:24 Page:659-669
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Lemmers Richard J.L.F.,Goeman Jelle J.,van der Vliet Patrick J.,van Nieuwenhuizen Merlijn P.,Balog Judit,Vos-Versteeg Marianne,Camano Pilar,Ramos Arroyo Maria Antonia,Jerico Ivonne,Rogers Mark T.,Miller Daniel G.,Upadhyaya Meena,Verschuuren Jan J.G.M.,Lopez de Munain Arregui Adolfo,van Engelen Baziel G.M.,Padberg George W.,Sacconi Sabrina,Tawil Rabi,Tapscott Stephen J.,Bakker Bert,van der Maarel Silvère M.

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Reference38 articles.

1. Population-based incidence and prevalence of facioscapulohumeral dystrophy;Neurology,2014

2. Padberg G.W. Facioscapulohumeral disease 1982 The Netherlands Leiden University PhD thesis (http://hdl.handle.net/1887/25818)

3. Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions;Curr. Opin. Neurol.,2011

4. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis;Ann. Neurol.,2001

5. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy;Nat. Genet.,1992

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double Trouble: A Comprehensive Study Into Unrelated Genetic Comorbidities in Adult Patients with Facioscapuluhumeral Muscular Dystrophy Type I;2024-09-12

2. SMCHD1 activates the expression of genes required for the expansion of human myoblasts;Nucleic Acids Research;2024-07-12

3. Muscle strength, quantity and quality and muscle fat quantity and their association with oxidative stress in patients with facioscapulohumeral muscular dystrophy: Effect of antioxidant supplementation;Free Radical Biology and Medicine;2024-07

4. Systemic Pharmacotherapeutic Treatment of the ACTA1-MCM/FLExDUX4 Preclinical Mouse Model of FSHD;International Journal of Molecular Sciences;2024-06-26

5. DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis;Science Advances;2024-05-31